Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Day Breen

Neurology with Special Qualifications in Child Neurology Chattanooga, TN Medical Doctor

NPI 1508121765 CMS profile 576633

910 Blackford St, Chattanooga, TN 37403

Open in the dashboard

General payments

$7,672

268 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Day Breen of Chattanooga, TN is reported in the CMS Open Payments database as having received $7,672 across 268 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,305 43
2024 General $3,155 66
2023 General $1,042 46
2022 General $901 39
2021 General $249 14
2020 General $377 21
2019 General $643 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Day Breen
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Day Breen were reported at $1,305. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Day Breen Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $643 $262 $68–$1,313 $163
2020 $377 $188 $46–$1,222 $114
2021 $249 $183 $45–$1,356 $132
2022 $901 $229 $72–$1,177 $149
2023 $1,042 $269 $93–$1,195 $160
2024 $3,155 $300 $98–$1,428 $164
2025 $1,305 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. UCB, Inc. $1,759 69 payments
  2. LivaNova USA, Inc. $1,641 8 payments
  3. Jazz Pharmaceuticals Inc. $755 33 payments
  4. Neurelis, Inc. $731 17 payments
  5. Greenwich Biosciences, Inc. $340 13 payments
  6. Sunovion Pharmaceuticals Inc. $278 31 payments
  7. Eisai Inc. $264 15 payments
  8. SK Life Science, Inc. $212 7 payments
  9. Upsher-Smith Laboratories LLC $175 6 payments
  10. Catalyst Pharmaceuticals, Inc. $139 6 payments
  11. Other $1,376 63 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,514 265 payments
  2. Travel and Lodging $1,158 3 payments
Products named General payments · program years 2019–2025
  1. VNS Therapy $1,597 5 payments
  2. Epidiolex $1,074 45 payments
  3. Briviact $890 32 payments
  4. VALTOCO $731 17 payments
  5. Fintepla $458 25 payments
  6. Nayzilam $358 10 payments
  7. APTIOM $341 36 payments
  8. Fycompa Neurology $264 15 payments
  9. Evrysdi $143 4 payments
  10. FYCOMPA Neurology $139 6 payments
  11. Other $1,528 69 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

268 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record